Nessuna connessione a internet — viene mostrata la versione salvata della pagina.

Amgen Inc

USUSD
← Allo Screener

Amgen Inc (HK:4332) — Biotechnology: Biological Products (No Diagnostic Substances). Numero di borse in cui sono quotate le azioni della società: 4. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.

Informazioni sull'Azienda

Sito Web
amgen.com
Relazioni con gli Investitori
investors.amgen.com/
Settore
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sede Centrale
Thousand Oaks, United States
Amministratore Delegato
Robert A. Bradway
Dipendenti
17 900
Fondata
1980
Revocata dalla Quotazione
10.10.2026 (HK:4332)
Azioni in Circolazione
540.63 Mln al 2026-07-30
Flottante
539.16 Mln
Capitalizzazione di Mercato
226.05 Mld USD
Insider
0.23%
Investitori Istituzionali
85.02%
Settore (SIC)
Biological Products, (No Diagnostic Substances)
Forma Giuridica
XTIQ
ISIN
US0311621009
LEI
62QBXGPJ34PQ72Z12S66
Payout Ratio
60.4%
FCF
10.2 Mld USD
52%
Debito
57.3 Mld USD
4.3 anni di FCF
Serie di Dividendi
15 a.
Utili, FCF e dividendi pagati — per i 12 mesi fino a 30.06.2026 (l'ultimo rapporto dell'azienda).
Descrizione

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Borse e Ticker

BorsaTickerValutaPrezzoTipo
US USA StocksAMGN principaleUSD414.87 +1.82%azioni ordinarie
HK Hong Kong Stock Exchange4332 secondariaHKD—
LSE London Stock Exchange0R0T IOBUSD411.854 +1.17%azioni ordinarie
MX Mexican Stock ExchangeAMGN secondariaMXN7 500.0098 +0.00%azioni ordinarie
XETRA XetraAMG secondariaEUR367.95 -1.39%azioni ordinarie

Prezzo su 3 Mesi

HK:4332 non ha registrato operazioni negli ultimi 3 mesi — il grafico mostra US:AMGN
giorno di rialzo giorno di ribasso data di stacco del dividendo data di pagamentoPassa il mouse / tocca un giorno — prezzi di apertura, chiusura, massimo e minimo

Dividendi

All'anno, US:AMGN: 9.94 USD (4 pag.)

Amgen Inc (AMGN) paga dividendi trimestralmente. All'anno (12 mesi fino all'ultimo pagamento annunciato): 9.94 USD per azione (pagamenti: 4). Questo rappresenta circa il 2.40% del prezzo attuale delle azioni. In base alla storia dei pagamenti, la prossima data ex-dividendo è prevista intorno al 20.11.2026. Storia dei dividendi ininterrotta: 15 anni.

Data ExPagamentoImporto%TipoTicker
2026-08-212026-09-112.5200 USD0.6/2.4 %trimestraleUS:AMGN
2026-05-152026-06-052.5200 USD0.6/2.4 %trimestraleUS:AMGN
2026-02-132026-03-062.5200 USD0.6/2.3 %trimestraleUS:AMGN
2025-11-212025-12-122.3800 USD0.6/2.3 %trimestraleUS:AMGN
2025-08-222025-09-122.3800 USD0.6/2.3 %trimestraleUS:AMGN
2025-05-162025-06-062.3800 USD0.6/2.2 %trimestraleUS:AMGN
2025-02-142025-03-072.3800 USD0.6/≈2.3 %trimestraleUS:AMGN
2024-11-182024-12-092.2500 USD0.5/≈2.2 %trimestraleUS:AMGN
2024-08-162024-09-062.2500 USD0.5/≈2.2 %trimestraleUS:AMGN
pubblicità

Principali Azionisti

DetentoreQuotaAzioniData del Rapporto
Blackrock Inc.9.13%49.36 Mln2026-06-30
Vanguard Capital Managem…6.52%35.25 Mln2026-06-30
State Street Corporation5.65%30.56 Mln2026-06-30
Capital World Investors5.38%29.08 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…3.17%17.13 Mln2026-06-30
Invesco Ltd.3.02%16.32 Mln2026-06-30
Geode Capital Management…2.9%15.7 Mln2026-06-30
Charles Schwab Investmen…2.78%15.03 Mln2026-06-30
Vanguard Portfolio Manag…2.75%14.85 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%13.99 Mln2026-06-30
Morgan Stanley2.53%13.65 Mln2026-06-30
Invesco QQQ Trust, Serie…2.15%11.61 Mln2026-08-31
SCHWAB STRATEGIC TRUST-S…1.81%9.79 Mln2026-05-31
Income Fund of America1.44%7.76 Mln2026-06-30
iShares Trust-iShares Co…1.35%7.28 Mln2026-07-31
Wells Fargo & Company1.34%7.24 Mln2026-06-30
AMERICAN BALANCED FUND1.31%7.09 Mln2026-06-30
Fidelity Concord Street…1.29%6.98 Mln2026-07-31
SPDR S&P 500 ETF TRUST-S…1.22%6.6 Mln2026-08-31
WASHINGTON MUTUAL INVEST…1.16%6.27 Mln2026-06-30
BRADWAY ROBERT A (Chief…≈0.12%657 2992026-05-05
SANTOS ESTEBAN (Officer)≈0.02%84 2792026-05-05
GORDON MURDO (Officer)≈0.01%51 8372026-05-05
GRIFFITH PETER H. (Chief…≈0.01%50 7062026-05-05
REESE DAVID M. (Chief Te…≈0.01%42 8122026-05-05
GRAHAM JONATHAN P (Gener…≈0.01%40 2112026-05-05
BRADNER JAMES E. (Office…≈0.01%30 4622026-05-05
ECKERT ROBERT ANDREW (Di…≈0%26 2512026-05-19
JACKS TYLER (Director)≈0%18 2842026-05-19
KULLMAN ELLEN JAMISON (D…≈0%14 5362026-05-19